PYC Therapeutics LimitedASX: PYC

RP11 program - presentation at euretina 2026

· Issued by PYC Therapeutics Limited via ASX

Filed with ASX ·

pyctx.com | ACN 098 391 961 1 2 October 2026 RP11 PROGRAM - PRESENTATION AT EURETINA 2026 • PYC is a precision medicine company dedicated to changing the lives of patients with genetic diseases who have no treatment options available • The Company is progressing a drug candidate (known as...

View Attachment

6ix hasn’t read this filing yet.

PYC Therapeutics Limited on 6ix

In the deck

Earlier from PYC Therapeutics

Later from PYC Therapeutics

All PYC Therapeutics news releases